Pharmateca
ISSN 2073-4034 (Print)
ISSN 2414-9128 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
Helicobacter pylori
antibacterial therapy
arterial hypertension
breast cancer
bronchial asthma
chemotherapy
children
chronic obstructive pulmonary disease
diabetes mellitus
gastroesophageal reflux disease
insulin resistance
metabolic syndrome
non-steroidal anti-inflammatory drugs
osteoporosis
pregnancy
probiotics
proton pump inhibitors
stroke
type 2 diabetes mellitus
vitamin D
Home
>
Search
>
Author Details
Author Details
Жукова, Л. Г
Issue
Section
Title
File
No 2S (2008)
Articles
Effektivnost' i bezopasnost' lapatiniba v kombinatsii s kapetsitabinom pri lechenii bol'nykh HER-2 pozitivnym metastaticheskim rakom molochnoy zhelezy
No 18 (2012)
Articles
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
No 8 (2013)
Articles
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
No 8 (2014)
Articles
DVOYNAYa BLOKADA HER2-PETsEPTOPA - NOVOE NAPRAVLENIE V LEChENII RAKA MOLOChNOY ZhELEZY S GIPEREKSPRESSIEY HER2
No 17 (2014)
Articles
Eribulin v lechenii metastaticheskogo raka molochnoy zhelezy s troynym negativnym fenotipom
No 17 (2014)
Articles
Pertuzumab - novyy vzglyad na HER2-polozhitel'nyy metastaticheskiy rak molochnoy zhelezy
No 8 (2016)
Articles
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
No 8 (2016)
Articles
MODERN POSSIBILITIES OF MEDICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER
No 8 (2016)
Articles
CLINICAL CASE OF SUCCESSFUL TREATMENT OF METASTATIC COLORECTAL CANCER WITH ACHIEVEMENT OF COMPLETE PATHOMORPHOLOGICAL RESPONSE (FIRST LINE CHEMOTHERAPY)
No 17 (2016)
Articles
FIRST-LINE ENDOCRINE THERAPY OF HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER. TIME OF CHANGE AFTER A LONG-TERM CALM PERIOD
No 17 (2016)
Articles
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
No 8 (2017)
Articles
Ixempra - new possibilities of cytostatic therapy of breast cancer
No 17 (2017)
Articles
Palbociclib - new possibilities of therapy of hormon-positive HER2-negative breast cancer
Vol 28, No 7 (2021)
Articles
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Vol 28, No 7 (2021)
Articles
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP